ACE2 and COVID-19: ACE2 is also expressed, to a lesser degree, by glomerular parietal cells/podocytes, which could potentially be related to the significant proteinuria seen in COVID-19-associated AKI, although preliminary analyses suggest this proteinuria is primarily tubular in origin [24,110,111].